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Abstract
Background and Objectives: Two community studies outside the US showed asymptomatic
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in adults, but not
in children <10 years of age. In this study, we assessed the prevalence of asymptomatic SARS-
CoV-2 infection in children and adults in Marion County, Indiana.
Methods: Individuals living in Marion County with no symptoms of coronavirus 2019 disease
(COVID-19) within seven days of enrollment were eligible for this cross-sectional household
study. Study kits were delivered to the participant’s residence for self-swabbing, picked up by
the study team, and tested by polymerase chain reaction (PCR) for SAR-CoV-2 infection.
Results: Five hundred eleven nasal swabs were collected from 119 children and 392 adults ≥18
years of age. One participant (seven years of age) tested positive, for an overall study
prevalence of 0.2% (95% CI 0, 0.6%). The participant had no known contact with a person with
SARS-CoV-2 infection, and five family members tested negative for infection. The child and
family members all tested negative for infection 10 and 20 days after the first test, and none
developed symptoms of COVID-19 for 20 days after testing.
Conclusions: Asymptomatic SARS-CoV-2 infection can occur in children <10 years with no
known COVID-19 exposure. Large cohort studies should be conducted to determine prevalence
of asymptomatic infection and risk of transmission from asymptomatic infection in children
and adults over time.
Categories: Pediatrics, Infectious Disease, Public Health
Keywords: pediatric, child, transmission
Introduction
A growing body of evidence suggests that asymptomatic and pre-symptomatic cases may
significantly contribute to the spread of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19) [1-4]. It has been
suggested that children are a reservoir for asymptomatic infection, but population-based
studies in Iceland and Italy that assessed symptomatic and asymptomatic SARS-CoV-2
infection found no infections in children <10 years of age [3,5].
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An understanding of the prevalence of asymptomatic SARS-CoV-2 infection in US communities
is critical to designing effective infection prevention strategies. Data on asymptomatic
infection in US children and adults in the community are not currently available. For this
reason, we conducted a community-based study of the prevalence of asymptomatic SARS-CoV-
2 infection in adults and children in Marion County, Indiana.
Materials And Methods
Study design, population, and setting 
We conducted a cross-sectional household study of prevalence of asymptomatic SARS-CoV2
infection, titled Tracing Asymptomatic COVID-19 Through Indianapolis Communities
(TACTIC) in Marion County, Indiana. Marion County, which encompasses the city of
Indianapolis, is the largest county in Indiana with a population of 954,670 in 2018, with
235,211 children <18 years of age. Individuals were eligible if they resided in a zip code within
Marion County and did not show any of the following symptoms within seven days of
enrollment: temperature >100.5oF (taken orally, axillary or rectally), new onset cough, new
onset diarrhea, new onset shortness of breath, or new onset sore throat. Individuals were
excluded if they had previously tested positive for SARS-CoV-2 by polymerase chain reaction
(PCR), or were unable to provide informed consent. Participants were enrolled and tested
between April 27, 2020 and May 15, 2020. This study was reviewed and approved by the Indiana
University Institutional Review Board (IRB).
Subject screening and enrollment
The study recruitment and enrollment strategy is outlined in Figure 1. Participants were
recruited using a state-wide research registry, All IN for Health, which has 4,093 households in
Marion County. A description of the study and directions on how to participate and enroll in
the All IN for Health registry if interested were circulated through social media and local news
outlets, including television and websites. Households with primarily underrepresented
minorities (URM) were first invited to participate, and one week later, a subset of households
was chosen according to the household having children, having newly registered URM, or
according to the need for proportionate representation from 10 zip code clusters that comprised
all of Marion County. Interested participants were sent an invitation to the screening survey
using the secure, web-based software platform Research Electronic Data Capture (REDCap)
hosted at Indiana University [6]. Eligible household members were then given a consent or
assent (child aged 12-17) document to complete.
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FIGURE 1: Flow chart of recruitment and enrollment strategy
for the Tracing Asymptomatic COVID-19 Through Indianapolis
Communities (TACTIC) study.
Sample collection and testing 
After obtaining informed consent, participants were directed to the study website with
instructions and a video of nasal swab collection procedures [7]. Study participants were
confirmed to be asymptomatic via REDCap prior to delivery of study kits with swabs and viral
transport medium vials. After nasal swabbing by participants, sealed kits were picked up and
swabs stored in a research laboratory at 4oC until transport within 24 hours to the Purdue
Animal Disease Diagnostic Lab, a Clinical Laboratory Improvement Amendments (CLIA)-
certified lab, for PCR testing. Viral RNA was isolated using the MagMax Viral/Pathogen Nucleic
Acid Isolation Kit (Thermo Fisher Scientific, Waltham, MA) with a KingFisher™ Flex Magnetic
Particle Processor with 96 Deep-Well Head (Thermo Fisher Scientific), and testing for SARS-
CoV2 was done by real-time polymerase chain reaction (RT-PCR) using the TaqPath™ RT-PCR
COVID-19 Kit (Thermo Fisher Scientific) with an Applied Biosystems™ 7500 Fast Real-Time
PCR Instrument used with SDS Software v1.5.1 (Thermo Fisher Scientific) and the data
analyzed and interpreted using the Applied Biosystems™ COVID-19 Interpretive Software
(Thermo Fisher Scientific). This multiplex assay detects the ORF1ab, N gene, and S gene of the
SARS-COV-2 virus. The kit also contains an exogenous extraction control (MS2 Phage Control)
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to confirm nucleic extraction and monitor for PCR inhibition. 
Statistical analysis
Based on previous studies finding a low overall community prevalence [3,5], the study sample
size had the power to detect a 1% prevalence (95% confidence interval [CI] 0.1, 1.9%) with 95%
confidence interval for proportion based on normal approximation of asymptomatic infection.
All other study data were descriptive.
Results
Characteristics of the study population
Nasal swabs were collected on 511 participants, including 119 children <18 years of age, and
392 individuals ≥18 years of age. Distribution of county and study population by age group is
shown in Table 1. Racial and ethnic characteristics of the study and county populations, by zip
code cluster and overall, are shown in Figure 2. 
N (%) Study Population (N=511) Marion County a (N=954,670)
Age, years (median) 36 34.5
   Preschool (0 to 4) 22 (4.3) 68,903 (7.2)
   School Age (5 to 17) 97 (19.0) 166,308 (17.4)
   College Age (18 to 24) 30 (5.9) 88,123 (9.2)
   Young Adult (25 to 44) 175 (34.2) 284,566 (29.8)
   Older Adult (45 to 64) 136 (26.6) 226,412 (23.7)
   Seniors (65 and older) 51 (10.0) 120,358 (12.6)
TABLE 1: Age distribution in study population compared to Marion County residents.
a Based on stats.indiana.edu
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FIGURE 2: Map of Marion County, Indiana, by zip code cluster,
and proportion of population within zip code cluster by race
and ethnicity.
Using American Community Survey data, zip codes with similar demographics were grouped into
ten clusters. This figure shows a cluster’s racial and ethnic breakdown, in terms of overall
population percentage (the black horizontal bar) and the study participant percentage (the blue
vertical bars). Data and demographic analysis provided by The Polis Center at IUPUI.
SARS-CoV-2 PCR testing results
Among the 511 participants tested, one participant, a seven-year-old boy, tested positive for
SARS-CoV-2 (prevalence 0.2% [95% CI 0, 0.6%]). The prevalence among children (n=119) was
0.8% (95% CI 0, 2.5%). The one child who tested positive was biracial (African-
American/Caucasian) and lived in a household with his mother and five siblings. One child
declined study participation. The other four children and the mother were all negative for
SARS-CoV2 infection. Neither the infected child nor anyone else in the household reported
2020 Wood et al. Cureus 12(8): e9794. DOI 10.7759/cureus.9794 5 of 8
having contact with a person known to have COVID-19. The cycle threshold (Ct) values for the
three target gene PCR reactions were 23-25, low levels indicating a significant viral load. Ten
days after testing, the child, siblings, and mother all tested negative on repeat PCR testing 10
and 20 days after initial testing and all remained asymptomatic during this period. Among the
392 asymptomatic adults ≥18 years of age, none tested positive for SARS-CoV-2 infection
(prevalence 0%).
Discussion
Multiple studies from China have reported asymptomatic SARS-CoV-2 infection in children, but
these studies involved children in contact with infected individuals and were not community
surveys of asymptomatic infection [1,2]. Community surveys in Iceland and Italy that included
symptomatic and asymptomatic individuals found a low prevalence of infection (0.8% to 2.6%),
and both studies found no infection in children <10 years of age [3,4]. In the state of Indiana, a
community prevalence study of individuals >12 years of age found an active infection rate (by
PCR) of 1.7% and an overall prevalence of current (PCR) or previous infection (SARS-CoV-2
antibody) of 2.8% [8]. Prevalence of asymptomatic infection in this study was 0.76%, within the
range of our finding of 0.2% prevalence in the population [8]. Despite the concern about spread
of SARS-CoV-2 infection from asymptomatic individuals in the community, there have been no
published studies of SARS-CoV-2 infection in asymptomatic adults and children 12 years and
under in the United States to date.
In the present study, we found no asymptomatic infection in 392 adults ≥18 years of age, but
found that one of 119 asymptomatic children ≤18 years was infected (prevalence 0.8%, 95% CI
0, 2.5%). The sole infected individual was seven years of age, demonstrating, contrary to prior
studies, that children under 11 years of age in the community may carry asymptomatic
infection. The source of the child’s infection was unclear, as no other household members
tested positive. It is possible other family members in the home were previously infected and
no longer shedding. Future serologic studies would be helpful and are planned. The positive
result was reported to the Indiana State Department of Health for further evaluation and
contact tracing.
The positive test rate in the state of Indiana during the study period was 11.3%, with an average
of 591 positive individuals per day [9]. Our study's finding of a very low prevalence of
asymptomatic infection provides reassurance on the benefits of the state implementation of
social distancing measures, which went in to effect March 24th with a stay at home order and a
phased reopening starting May 11th in Marion county. Even with this low prevalence, infection
in one child out of 119 tested (0.84%) yields an estimate of 1977 children asymptomatically
infected in Indianapolis/Marion County (95% CI 0, 6209). The large confidence intervals
demonstrate the preliminary nature of this data. Larger studies of asymptomatic infection that
include young children are needed to determine the relative prevalence of asymptomatic
infection in children and adults with greater precision. Additionally, longitudinal studies across
multiple geographic areas are needed to determine how prevalence varies in different areas,
especially as social distancing measures are relaxed. Testing of antibodies to SARS-CoV-2 in
these individuals could help to determine the rate of past infection, another important measure
for which there is little data in children. Antibody testing is planned in this cohort. The
increasing reports of multisystem inflammatory syndrome in children (MIS-C) temporally
associated with prior SARS-CoV-2 infection, most of which appears to have been asymptomatic
[10-12], underscore the importance and urgency of increasing our understanding of
asymptomatic SARS-CoV-2 infection and its potential sequelae in children.
Strengths of this study include the specific investigation of asymptomatic individuals; use of
community engagement to recruit a representative cohort of individuals; the innovative
sample distribution and collection methods, which made the study possible in a period of
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active SARS-CoV-2 transmission; use of self/parent-administered nasal swabs, recently shown
to be similar in sensitivity for SARS-CoV-2 detection to nasopharyngeal swabs [13,14], which
made home testing of children feasible; and the intentional inclusion of both children and
adults in testing. The primary limitations were the relatively small sample size for a population
study and the non-random selection of study participants. Despite the small sample size, we
were able to detect low frequency infection, but the 95% confidence intervals of the estimates
included zero, so the study data are best viewed as important initial data on which to base
future studies of asymptomatic infection in children and adults. We chose a non-random
recruitment process because we had a research registry that mirrored overall population
demographics and therefore was likely to provide a sample representative of the geographic
and racial diversity of the county/city population. Additionally, study enrollment required
access to internet/email which may have biased our population to a higher socioeconomic class.
Random selection might have derived a population more fully representative of the county
population, but participation rates would likely have been far lower, and the final sample may
not have been substantially different from the sample we obtained.
Conclusions
In the present study, we found asymptomatic SARS-CoV-2 infection in one seven-year-old child
with no history of known SARS-CoV-2 exposure, out of 119 children tested (prevalence 0.84%,
95% CI, 0, 2.5%) and in none of the 392 adults ≥18 years of age tested. The study demonstrates
that children <10 years of age with no known SARS-CoV-2 exposure may harbor asymptomatic
SARS-CoV-2 infection. In this instance the child did not transmit infection to close
contacts. The study sets the stage for future larger studies of asymptomatic infection in
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